Connect your AI

OS Therapies OSTX Stock Issued During Period Value Sale Of Common Stock To Investors

Stock Issued During Period Value Sale Of Common Stock To Investors at other companies

Spectral AI, Inc.MDAI

$543K—

NXT

Next Technology HoldingNXTT

$2.01M—

TMC the metals company Inc.TMC

$6.97M—

CO2 Energy Transition Corp. Common StockNOEM

265K—

Richtech Robotics Inc.RR

$9.18M+13.9%

HTF

Heartflow, Inc. Common StockHTFL

$3.34M+478%

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:StockIssuedDuringPeriodValueSaleOfCommonStockToInvestors.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's stock issued during period value sale of common stock to investors.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's stock issued during period value sale of common stock to investors?: OS Therapies (OSTX) reported stock issued during period value sale of common stock to investors of $132.54K in Q4 2025.
What does stock issued during period value sale of common stock to investors mean?: The total proceeds received from the direct sale of common stock to external investors during the period. This serves as a primary indicator of the company's ability to raise external capital through equity markets.